Abstract
In contrast to other forms of voiding dysfunction, underactive bladder (UAB) has traditionally received little research or educational attention. This is changing as our understanding of the underlying mechanisms of detrusor dysfunction and other forms of underactive bladder improves. In addition, the impact of UAB on patient symptoms, general and health-related quality of life, and caregiver burden are becoming more recognized. However, there remains a paucity of data on the subject, and an extensive need for additional research and education on the topic. This paper explores the current state of knowledge about UAB with an emphasis on education regarding the condition and conservative methods of assessment and treatment. Recommendations for future work in this area are considered.
Similar content being viewed by others
References
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-committee of the International Continence S (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178
Resnick NMEA, Yalla SV (1995) Age and the lower urinary tract: what is normal? Neurourol Urodyn 14:577–579
Smith PP (2010) Aging and the underactive detrusor: a failure of activity or activation? Neurourol Urodyn 29(3):408–412. doi:10.1002/nau.20765
Yoshida M, Inadome A, Maeda Y, Satoji Y, Masunaga K, Sugiyama Y, Murakami S (2006) Non-neuronal cholinergic system in human bladder urothelium. Urology 67(2):425–430. doi:10.1016/j.urology.2005.08.014
Nuotio M, Tammela TL, Luukkaala T, Jylha M (2003) Predictors of institutionalization in an older population during a 13-year period: the effect of urge incontinence. J Gerontol A Biol Sci Med Sci 58(8):756–762
Fry CH, Bayliss M, Young JS, Hussain M (2011) Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle. BJU Int 108(2 Pt 2):E91–E96. doi:10.1111/j.1464-410X.2010.09845.x
Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, Oh JJ, Lee SC, Jeong CW, Yoon CY, Hong SK, Byun SS, Lee SE (2012) Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol 53(5):342–348. doi:10.4111/kju.2012.53.5.342
Abarbanel J, Marcus EL (2007) Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology 69(3):436–440. doi:10.1016/j.urology.2006.11.019
van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M (2011) Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 30(5):723–728. doi:10.1002/nau.21097
Everaerts W, De Ridder D (2013) Unravelling the underactive bladder: a role for TRPV4? BJU Int 111(2):353–354
Jiang HH, Kokiko-Cochran ON, Li K, Balog B, Lin CY, Damaser MS, Lin V, Cheng JY, Lee YS (2013) Bladder dysfunction changes from underactive to overactive after experimental traumatic brain injury. Exp Neurol 240:57–63. doi:10.1016/j.expneurol.2012.11.012
Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 65(2):389–398. doi:10.1016/j.eururo.2013.10.015
Sekido N, Jyoraku A, Okada H, Wakamatsu D, Matsuya H, Nishiyama H (2012) A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model. Neurourol Urodyn 31(7):1190–1196. doi:10.1002/nau.21255
Young JS, Johnston L, Soubrane C, McCloskey KD, McMurray G, Eccles R, Fry CH (2013) The passive and active contractile properties of the neurogenic, underactive bladder. BJU Int 111(2):355–361. doi:10.1111/j.1464-410X.2012.11300.x
Miyazato M, Yoshimura N, Chancellor MB (2013) The other bladder syndrome: underactive bladder. Rev Urol 15(1):11–22
Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society C (2006) Epidemiologic survey of lower urinary tract symptoms in Japan. Urology 68(3):560–564. doi:10.1016/j.urology.2006.03.035
Tomoe (2014) Assessment of the usefulness and optimal method of administration of distigmine bromide for the treatment of voiding dysfunction due to underactive detrusor. Paper presented at the AUGS/IUGA Scientific Meeting, Washington, DC, July 22–26
Wound Ostomy and Continence Nurses Society (2009) Indwelling urinary catheters: best practice for clinicians. https://wocn.site-ym.com/store/ViewProduct.aspx?id=692946
Wilde MH, McDonald MV, Brasch J, McMahon JM, Fairbanks E, Shah S, Tang W, Scheid E (2013) Long-term urinary catheter users self-care practices and problems. J Clin Nurs 22(3–4):356–367. doi:10.1111/jocn.12042
Khan A, Housami F, Melotti R, Timoney A, Stickler D (2010) Strategy to control catheter encrustation with citrated drinks: a randomized crossover study. J Urol 183(4):1390–1394. doi:10.1016/j.juro.2009.12.024
Wilde MH, Zhang F, Fairbanks E, Shah S, McDonald MV, Brasch J (2013) Perceived value of a urinary catheter self-management program in the home. Home Healthc Nurse 31(9):465–473. doi:10.1097/NHH.0b013e3182a89791
Wilde MH, Brasch J, Zhang Y (2011) A qualitative descriptive study of self-management issues in people with long-term intermittent urinary catheters. J Adv Nurs 67(6):1254–1263. doi:10.1111/j.1365-2648.2010.05583.x
Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ (2010) Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol 184(1):213–217. doi:10.1016/j.juro.2010.03.008
Acknowledgments
Funding for this conference was made possible (in part) by 1R13AG047010 from the National Institute on Aging. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government.
Conflict of interest
Michael B. Chancellor has conflict of interest related to Allergan, Astellas, Cook, Lipella, Medtronic, Pfizer, Targacept. Mary H. Wilde has a conflict of interest related to NovaBay Pharmaceutical. There is no conflict of interest for Tomas Griebling, Catherine E. DuBeau, George Kuchel, Michelle Lajiness, Hikaru Tomoe, Ananias Diokno, or Andrew Vereecke.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Griebling, T.L., DuBeau, C.E., Kuchel, G. et al. Defining and advancing education and conservative therapies of underactive bladder. Int Urol Nephrol 46 (Suppl 1), 29–34 (2014). https://doi.org/10.1007/s11255-014-0799-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0799-6